All Products

Hexarelin 5 mg

Potent Growth Hormone Releasing Peptide

Lab Tested

Substance: Hexarelin (Examorelin)
Strength: 5 mg/vial
Form: Lyophilized powder
Packaging: 2 mL glass vial
Manufacturer: Dragon Pharma, Europe

Authentic Dragon Pharma Product

Free Shipping on Orders $800+

Discreet Packaging Guaranteed

$45.00 $75.00

Warehouse :

International

U.S. Domestic

You will save $30.00

Dragon Pharma Hexarelin

Hexarelin 5 mg delivers a research-grade dose of Examorelin, widely regarded as the most potent synthetic hexapeptide in the growth hormone releasing peptide (GHRP) class. With the amino acid sequence His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH₂, Hexarelin exhibits exceptional binding affinity to the growth hormone secretagogue receptor (GHS-R1a), triggering explosive releases of growth hormone (GH) that can reach up to 10-20 times baseline levels in research models. Its unique structural modification (D-2-methyl-Trp) enhances metabolic stability and receptor interaction compared to earlier GHRPs, while maintaining the ability to suppress somatostatin—the primary inhibitor of GH secretion. This dual-action mechanism, combined with its resistance to enzymatic degradation, makes Hexarelin the gold standard for research requiring maximal GH stimulation.

For bodybuilders, athletes, and endocrine researchers in the USA, Dragon Pharma Hexarelin 5 mg represents the pinnacle of GH secretagogue research tools. Its unparalleled potency makes it particularly valuable for studies on extreme body recomposition, accelerated recovery from intense training or injury, and investigations into the upper limits of GH-mediated anabolism. Research focuses on its potential to dramatically increase lean body mass through enhanced protein synthesis, promote significant fat loss via lipolysis, strengthen connective tissues, improve bone density, and potentially enhance cardiovascular function through GH-mediated effects. The 5 mg concentration is optimally sized for research protocols requiring potent but controlled GH stimulation. Manufactured by Dragon Pharma under stringent quality control in certified European laboratories, this vial ensures researchers receive a pure, precisely dosed peptide for investigating the boundaries of endocrine manipulation and performance enhancement.

Key Benefits:

Maximum GH Stimulation: Most potent GHRP available for research, capable of increasing GH levels 10-20 fold above baseline in study models.
Enhanced Metabolic Stability: Structural modification (D-2-methyl-Trp) provides resistance to enzymatic degradation, extending activity compared to other GHRPs.
Extreme Body Recomposition Potential: Ideal for research on simultaneous muscle growth and fat loss through maximal GH/IGF-1 pathway activation.
Cardioprotective Research Applications: Unique among GHRPs for potential cardiovascular benefits studied in cardiac ischemia and heart failure models.
Optimal Research Concentration: 5 mg per vial provides potent material for controlled studies while allowing precise dose titration in sensitive research models.

Each 2 mL vial contains 5 mg of high-purity Hexarelin (Examorelin) hexapeptide as a sterile lyophilized powder, synthesized using advanced peptide chemistry under Dragon Pharma's pharmaceutical-grade manufacturing standards.

Product Specifications

Product Name	Hexarelin 5 mg
Manufacturer	Dragon Pharma
Substance	Hexarelin (Examorelin)
Packaging	2 mL glass vial, lyophilized powder
Lab Test Result	5.34 mg (106.8% of label claim) - September 2025 batch
Half-Life	Approximately 1-2 hours (longer than other GHRPs due to metabolic stability)
Recommended Cycle	Research cycles typically 4-8 weeks due to potency, with 4-6 week breaks to prevent desensitization.
Form	Lyophilized (freeze-dried) powder for reconstitution
Aromatization	Not applicable (non-hormonal peptide)
Dosage (Research Models)	Typically studied with 1-2 daily administrations due to potency and longer half-life (vs. 2-3 for other GHRPs).

Usage Guidelines

Research Application Only: This information summarizes scientific literature for educational context. Dragon Pharma Hexarelin 5 mg is a research chemical for laboratory investigation, not for human consumption.

In experimental settings, Hexarelin is reconstituted with bacteriostatic water. Due to its exceptional potency and longer half-life compared to other GHRPs, research protocols often use fewer daily administrations—typically 1-2 times daily versus 2-3 for GHRP-2 or GHRP-6. Common timing includes morning and/or post-training administration. The peptide's potency requires careful dose titration in study designs, often starting at the lower end of the research range. Administration on an empty stomach or at least 2 hours post-meal maximizes effectiveness. Research cycles are typically shorter (4-8 weeks) with longer breaks (4-6 weeks) due to concerns about more rapid desensitization with such potent stimulation. Studies may include monitoring of not only GH/IGF-1 but also cortisol and prolactin, which Hexarelin can stimulate more than other GHRPs.

Potent Body Recomposition Research (4-6 weeks): 1-2 daily administration protocol focusing on maximal effects on lean mass, fat loss, and metabolic parameters, with careful monitoring.
Cardiovascular & Recovery Studies (6-8 weeks): Extended protocols investigating unique cardioprotective effects and accelerated recovery from injury or intense training.

Post Cycle Therapy (PCT):

As a potent GH secretagogue, Hexarelin does not suppress the HPTA, so traditional PCT with SERMs like Nolvadex is not applicable. However, due to its potency and potential for more rapid pituitary desensitization, extended breaks (4-6 weeks) between research cycles are crucial. Some protocols incorporate a switch to milder secretagogues like Ipamorelin during off-periods. For maintaining anabolic environment post-cycle, compounds like 1-Test Cyp could be studied in follow-up research.

Synergistic Research Combinations:

Hexarelin's potency makes it ideal for combination research with other powerful compounds. For maximal anabolic effects, it can be paired with androgens like Trenbolone 100. With GHRH analogs like CJC-1295 DAC, it creates unparalleled GH stimulation. For cutting phase studies, combining with Clenbuterol could examine synergistic fat loss. In recovery research, pairing with TB-500/BPC-157 blend may enhance tissue repair. For nutrient partitioning, related compounds could be included.

Third-Party Lab Tested

Dragon Pharma Hexarelin 5 mg Lab Test Result September 2025

2025-09-12

View Result

5.34 mg

Lab Analysis Note: The September 2025 third-party HPLC test confirms 5.34 mg of Hexarelin peptide per vial—106.8% of the labeled 5 mg. This overfill demonstrates Dragon Pharma's commitment to premium research products. Mass spectrometry verifies the correct hexapeptide sequence (His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH₂) with ≥98% purity, including the critical D-2-methyl-Trp modification that confers enhanced stability and potency.

Storage Instructions

Proper storage is essential to maintain the stability and potency of this high-value research peptide.

Unreconstituted Powder: Store the sealed vial in a freezer at -20°C (-4°F) or colder for long-term stability. In this lyophilized state, Hexarelin remains stable for up to 24 months. Protect from light and moisture, and avoid repeated freeze-thaw cycles.
After Reconstitution: Once reconstituted with bacteriostatic water, the solution must be refrigerated immediately at 2°C to 8°C (36°F to 46°F). The reconstituted solution is typically stable for research use for 4-6 weeks when refrigerated, benefiting from Hexarelin's enhanced metabolic stability. For best results, use within 30 days. Never freeze the liquid solution.
Important for Potency Preservation: Given Hexarelin's enhanced stability compared to other GHRPs, it may maintain potency slightly longer in solution, but standard refrigeration protocols should still be followed rigorously for research consistency.

What does hexarelin peptide do?

Hexarelin is the most potent growth hormone releasing peptide (GHRP) available for research. It powerfully stimulates GH secretion through dual mechanisms: activating the ghrelin receptor (GHS-R1a) on pituitary cells and suppressing somatostatin (the primary GH inhibitor). This can increase GH levels 10-20 fold in research models. Beyond GH stimulation, it uniquely demonstrates potential cardioprotective effects in cardiac research models and may influence cortisol and prolactin more than other GHRPs.

Is hexarelin better than Ipamorelin?

For research purposes, they serve different objectives. Hexarelin is FAR more potent (10-20x GH increase vs. 2-4x for Ipamorelin) but less selective—it stimulates cortisol and prolactin more. Ipamorelin is highly selective for GH with minimal other hormonal effects. Hexarelin is for studies requiring maximal GH stimulation; Ipamorelin for "cleaner," more physiological GH pulses. Hexarelin may cause more rapid desensitization due to its potency. The choice depends on research goals: maximum stimulation vs. selective, sustained stimulation.

Who should not use hexarelin peptide?

Research Considerations: Hexarelin is for laboratory use only. In study design, particular caution is warranted in research models involving:

Existing pituitary tumors or abnormalities (due to potent GH stimulation);
Cardiovascular conditions (despite potential benefits, its strong hormonal effects require careful monitoring);
Glucose regulation issues (GH affects insulin sensitivity);
Models where cortisol/prolactin elevation would confound results.

Its potency requires more conservative dosing and monitoring in research compared to milder GHRPs.

What makes Hexarelin more potent than other GHRPs?

Three key factors:

Structural modification: The D-2-methyl-Trp amino acid enhances receptor binding affinity and metabolic stability;
Greater receptor activation: More effectively triggers the intracellular signaling cascade after receptor binding;
Enhanced somatostatin suppression: More potently inhibits the primary GH suppressor. Additionally, it resists enzymatic degradation better than GHRP-2 or GHRP-6, maintaining active concentrations longer.

These factors combine to make it the most potent GH secretagogue in research.

Is Dragon Pharma Hexarelin 5 mg accurately dosed?

Yes, with exceptional precision. The September 2025 third-party lab test shows 5.34 mg per vial—106.8% of the labeled 5 mg—confirming premium quality with overfill. Mass spectrometry verifies the correct hexapeptide sequence including the critical D-2-methyl-Trp modification that defines Hexarelin's enhanced properties. With ≥98% purity, researchers receive a potent, accurately dosed peptide for maximum GH stimulation studies.

No customer reviews yet.